Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINERVA kidney transplant maintenance study
2006-003501-71Phase 4Terminated
- Sponsor
- Novartis
- Start
- May 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of mycophenolate sodium and cyclosporine in kidney allograft rejection and chronic rejection (2 arms), sponsored by Novartis. Started May 2007; status: terminated.
02
Drugs
mycophenolate sodiumcyclosporine
03
Conditions
kidney allograft rejectionchronic rejection
Beyond the preview
Go deeper on 2006-003501-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003501-71.